ConductScience.org, home

Paper36650239

Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin.

Allred CA and 5 others. Commun Biol, 2023. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin. Papers, record 36650239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36650239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin.
PubMed
Journal
Commun Biol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.62
iCite
Revised in PubMed
2023-02-05
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Allred CACurtis A
2Gormley CClaire
3Venugopal IIndu
4Li SShunzi
5McGuire MJMichael J
6Brown KCKathlynn Chttps://orcid.org/0000-0003-0012-9675

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Non-Small-Cell LungMajor topic
Lung NeoplasmsMajor topic
Antineoplastic AgentsMajor topic
Animals
Humans
Peptides
Peptide Library

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
1R01CA164447-01U.S. Department of Health & Human Services | National Institutes of Health (NIH)R01CA164447PubMed

Source NIH RePORTER

Download CSV of grants

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17542357Treatment of B-cell lymphomas with combination of bispecific antibodies and saporin.Lancet1995https://conductscience.org/library/papers/7542357PubMed
225758331Light-controlled endosomal escape of the novel CD133-targeting immunotoxin AC133-saporin by photochemical internalization - A minimally invasive cancer stem cell-targeting strategy.J Control Release2015https://conductscience.org/library/papers/25758331PubMed
317714513Lipopolyamine treatment increases the efficacy of intoxication with saporin and an anticancer saporin conjugate.FEBS J2007https://conductscience.org/library/papers/17714513PubMed
418935973Saporin induces multiple death pathways in lymphoma cells with different intensity and timing as compared to ricin.Int J Biochem Cell Biol2009https://conductscience.org/library/papers/18935973PubMed
524299061Combinatorial peptide libraries: mining for cell-binding peptides.Chem Rev2014https://conductscience.org/library/papers/24299061PubMed
627338475High in Vitro Anti-Tumor Efficacy of Dimeric Rituximab/Saporin-S6 Immunotoxin.Toxins (Basel)2016https://conductscience.org/library/papers/27338475PubMed
724670678Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer.Sci Rep2014https://conductscience.org/library/papers/24670678PubMed
824195949Intrathecal substance P-saporin in the dog: efficacy in bone cancer pain.Anesthesiology2013https://conductscience.org/library/papers/24195949PubMed
919789305A novel reduced immunogenicity bispecific targeted toxin simultaneously recognizing human epidermal growth factor and interleukin-4 receptors in a mouse model of metastatic breast carcinoma.Clin Cancer Res2009https://conductscience.org/library/papers/19789305PubMed
1028218037Immunotoxin: A new tool for cancer therapy.Tumour Biol2017https://conductscience.org/library/papers/28218037PubMed
1119764990ATG-saporin-S6 immunotoxin: a new potent and selective drug to eliminate activated lymphocytes and lymphoma cells.Br J Haematol2009https://conductscience.org/library/papers/19764990PubMed
1222475101Endocytosis and intracellular localisation of type 1 ribosome-inactivating protein saporin-s6.J Biol Regul Homeost Agents2012https://conductscience.org/library/papers/22475101PubMed
1323643966Photochemical internalization of CD133-targeting immunotoxins efficiently depletes sarcoma cells with stem-like properties and reduces tumorigenicity.Biochim Biophys Acta2013https://conductscience.org/library/papers/23643966PubMed
1432575752Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update.Biomolecules2020https://conductscience.org/library/papers/32575752PubMed
1531969331ANG1005, a Brain-Penetrating Peptide-Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases.Clin Cancer Res2020https://conductscience.org/library/papers/31969331PubMed
1622069735Immunotoxins and other conjugates containing saporin-s6 for cancer therapy.Toxins (Basel)2011https://conductscience.org/library/papers/22069735PubMed
1733536635Trends in peptide drug discovery.Nat Rev Drug Discov2021https://conductscience.org/library/papers/33536635PubMed
1826912181Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design.AAPS J2016https://conductscience.org/library/papers/26912181PubMed
1929870741Strategies to Reduce the Immunogenicity of Recombinant Immunotoxins.Am J Pathol2018https://conductscience.org/library/papers/29870741PubMed
2028941284Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolin.J Cell Physiol2018https://conductscience.org/library/papers/28941284PubMed

See all 58 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
40817125HACD3 promotes malignant progression of NSCLC by suppressing the MKK7/MAPK10 signaling axis.BMC Cancer2025https://conductscience.org/library/papers/40817125PubMed
40672665Advancing Cancer-Targeted Nanotherapies with Tumor Homing Peptides.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/40672665PubMed
39064917Cell-Penetrating Peptide-Mediated Biomolecule Transportation in Artificial Lipid Vesicles and Living Cells.Molecules2024https://conductscience.org/library/papers/39064917PubMed
38584554Neuropilin-1 Binding Peptide as Fusion to Diphtheria Toxin Induces Apoptosis in Non-small Cell Lung Cancer Cell Line.Curr Pharm Des2024https://conductscience.org/library/papers/38584554PubMed

Download CSV of cited by

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36650239

GET https://conductscience.org/api/papers/v1/36650239/references?page=2